Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from PharmPro

05:12 EST 21st February 2017 | BioPortfolio

Here are the most relevant search results for "PharmPro" found in our extensive news archives from over 250 global news sources.

More Information about PharmPro on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PharmPro for you to read. Along with our medical data and news we also list PharmPro Clinical Trials, which are updated daily. BioPortfolio also has a large database of PharmPro Companies for you to search.

Showing News Articles 1–25 of 3,400+ from PharmPro

Friday 17th February 2017

Remission Noted After 2 Years for Patients with Crohn’s Disease

NewsNew data shows Stelara (ustekinumab) maintained clinical response and remission after two years of treatment in patients with moderate to severe Crohn’s disease.

Cancer Researchers Urge Regular Genomic Profiling and Targeted Molecular Drugs

NewsDoctors treat deadly cancerous disorders with gene-guided, targeted therapy. Patients who faced a grim outlook from treatment-resistant disease are now reported to be thriving.

AstraZeneca Breast Cancer Tablet Meets Primary Endpoint

NewsLynparza meets primary endpoint in Phase III trial in BRCA-mutated metastatic breast cancer. The drug provided a statistically significant improvement in progression-free survival compared to chemotherapy.

Louisiana Company Agrees to Stop Selling Drugs, Supplements

NewsA Louisiana-based company agreed Thursday to stop making and marketing untested products that were labeled and advertised as treatments for heart disease, multiple sclerosis, cancer and other maladies.

Antibiotics Effective Against Drug-Resistant Bacteria in Pediatric Skin Infections

NewsIn a randomized controlled clinical trial, a multi-institution research team reports that daptomycin, part of a new class of antibiotics currently approved only for use in adults, is effective and well-tolerated in children.

Antibiotic s Effective Against Drug-Resistant Bacteria in Pediatric Skin Infections

NewsIn a randomized controlled clinical trial, a multi-institution research team reports that daptomycin, part of a new class of antibiotics currently approved only for use in adults, is effective and well-tolerated in children.

Thursday 16th February 2017

Maryland Health Officials Call for Drug Affordability Legislation

NewsThe Maryland General Assembly is considering a pair of Senate and House bills that would fight prescription drug price increases.

NewAge Plant Expansion to Add Manufacturing and Warehouse Space

NewsThe company cited the success of its AdvantaPure product line in announcing the expansion. The project will provide space for more clean room suites, inspection areas and warehousing.

Wednesday 15th February 2017

Scottish CMO to Open an Office in Massachusetts

NewsSymbiosis Pharmaceutical Services is set to open an office in North America in response to continued demand from U.S.-based biotechnology companies.

SGS Expands Elemental Impurity Testing Services at France Laboratory

NewsThe Villeneuve-la-Garenne site in France has invested in a new inductively coupled plasma mass spectrometry (ICP-MS) system, in a move to address the updated ICH Q3D regulatory guidelines on elemental impurities.

Revised U.S. tally: HIV Infections Fell 18 Percent in 6 Years

NewsThe Centers for Disease Control and Prevention found that between 2008 and 2014, new infections fell 56 percent in people who inject drugs.Cont

Allergan to Acquire Zeltiq, Bolstering Aesthetics and Regenerative Units

NewsAllergan to acquire Zeltiq for $2.47 billion. The move brings together Allergan's facial aesthetics, plastic surgery and regenerative medicine businesses.

Allergan to Purchase Zeltiq, Bolstering Aesthetics and Regenerative Units

NewsAllergan to acquire Zeltiq for $2.47 billion. The move brings together Allergan's facial aesthetics, plastic surgery and regenerative medicine businesses.

Merck Alzheimer's Drug Fails in One Study; Another Continues

NewsMerck's EPOCH study of verubecestat for the treatment of mild to moderate Alzheimer’s disease to stop for lack of efficacy. The APECS study in people with prodromal Alzheimer’s disease to continue.

Gilead Presents Phase 2 Data on HIV Treatment

NewsGilead presents new Phase 2 data on bictegravir, an investigational integrase strand transfer inhibitor for the treatment of HIV.

Tuesday 14th February 2017

Generic Pharmaceutical Association Becomes Association for Accessible Medicines

NewsGeneric and biosimilar manufacturers launch new brand and campaign to expand access to medicines. Campaign will emphasize that generics reduce drug costs, drive savings.

Antares Vision Moving Headquarters to Larger NJ Facility

NewsCompany provides serialization-based track and trace options for the pharmaceutical industry. The new site includes quadrupled warehouse space and areas for multiple simultaneous factory acceptance tests.

Axsome Therapeutics Receives FDA Fast Track for Depression Treatment

NewsAxsome Therapeutics receives FDA Fast Track designation for AXS-05 for treatment resistant depression. FDA move underscores the limited treatment options for the disorder, according to the company.

Sanofi Initiates Phase 2 Clinical Trial to Evaluate Parkinson's Therapy

NewsSanofi initiates Phase 2 clinical trial to evaluate therapy for genetic form of Parkinson’s disease. The trial will assess the drug’s dynamics, efficacy and safety.

Sanofi Initiates Phase 2 Clinical Trial to Evaluate Therapy for Genetic Form of Parkinson’s Disease

NewsSanofi initiates Phase 2 clinical trial to evaluate therapy for genetic form of Parkinson’s Disease.

Company Announces Pause for Drug After Price Criticism

NewsMarathon Pharmaceuticals temporarily halted the rollout of Emflaza (deflazacort) for use in the U.S. after some members of Congress expressed outrage over the $89,000 a year price tag.

Drug That Increases Survival Rate in Dogs May Help Humans

NewsDrug developed at University of Minnesota increases survival in dogs with cancer. Research shows potential for use in humans.

Medical Microbiologist: Scale Back the Widespread Use of Antibiotics

NewsKingston University London microbiology expert highlights importance of developing rapid diagnostic tests to combat drug resistance.

Monday 13th February 2017

Sanofi to Sell Select Consumer Healthcare Products to Ipsen for 83M Euro

NewsIpsen to acquire a portfolio of select consumer healthcare products from Sanofi. Transaction leverages Ipsen primary care infrastructure and accelerates conversion to OTx business model.

Sanofi to Sell Select Consumer Healthcare Products to Ipsen for Euro 83M

NewsIpsen to acquire a portfolio of select consumer healthcare products from Sanofi. Transaction leverages Ipsen primary care infrastructure and accelerates conversion to OTx business model.


Quick Search
Advertisement
 

News Quicklinks